Spot | Protein | Accession no. | Ratio of mean spot volume1 | |||
---|---|---|---|---|---|---|
T0 | 2w | 4w | 12w | |||
Protease inhibitors | ||||||
2 | Serine protease inhibitor 7 | P30941.2 | 0,24 ** | 0,19 ** | 0,28 ** | 0,28 ** |
4 | Serine protease inhibitor 7 | P30941.2 | 0,28 ** | 0,23 ** | 0,22 * | 0,16 * |
3 | Kunitz-type enzyme inhibitor S9C11 | AAL67830.1 | 0,37 * | 0,43 ** | 0,49 ** | 0,6 * |
6 | Putative miraculin | CAC40756.1 | 0,58 * | 0,53 ** | 0,62 ** | 0,42 * |
14 | Aspartic protease inhibitor 5 | P58519.1 | 0,69 | 0,37 * | n.d. | 0,65 * |
10 | Kunitz-type proteinase inhibitor | AAM21645.1 | 0,77 | 0,44 ** | 0,71 * | 0,23 * |
11 | Kunitz-type proteinase inhibitor | AAM21645.1 | 0,74 | n.d. | 0,24 *** | n.d. |
12 | Kunitz-type proteinase inhibitor | AAM21645.1 | 0,48 | 0,51 * | 0,52 ** | 0,43 ** |
19 | Putative miraculin | CAC40756.1 | 3,64 * | 5,02 ** | 2,85 ** | 4,34 ** |
20 | Cysteine protease inhibitor 1 | P20347.3 | n.d. | 4,21 *** | 2,81 *** | 3,32 ** |
21 | Proteinase inhibitor II | CAA27730 | 1,54 | 2,89 ** | 1,62 * | 0,99 |
22 | Proteinase inhibitor II | CAA27730 | 1,48 | 2,09 * | 1,45 * | 1,59 ** |
24 | Proteinase inhibitor II | CAA27730 | 2,89 * | 1,56 * | 1,25 * | 1,59 * |
Storage proteins | ||||||
1 | Patatin-2-Kuras 4 | Q3YJT0 | 0,43 * | 0,39 * | 0,55 *** | 0,47 ** |
13 | Patatin Group M-3 | Q2MY51 | 0,24 | 0,38 ** | 0,63 * | 0,40 * |
44 | Patatin-3-Kuras 1 | Q3YJS9.1 | 2,57 * | 3,37 * | 3,22 * | 2,04 |
45 | Patatin-3-Kuras 1 | Q3YJS9.1 | 2,99 * | 2,67 * | 3,20 * | 2,60 * |
46 | Patatin-3-Kuras 1 | Q3YJS9.1 | 1,51 | 2,26 | 2,07 * | 1,97 |
Lipid metabolism | ||||||
31 | Lipoxygenase | X95512.1 | 1,42 ** | 1,56 ** | 1,94 ** | 2,17 ** |
32 | Lipoxygenase | X95512.1 | 1,56 * | 2,02 ** | 1,65 ** | 1,79 * |
33 | Lipoxygenase | X95512.1 | 1,52 | 2,78 ** | 1,73 ** | 1,59 * |
34 | Lipoxygenase | X95512.1 | 1,66 | 3,71 * | 1,72 ** | 1,51 * |
35 | Lipoxygenase | X95512.1 | 1,45 | 3,90 * | 1,71 * | 1,65 |
36 | Phospholipase A1 | ABQ95989.1 | 3,20 *** | 2,82 *** | 7,45 ** | 2,92 * |
39 | Phospholipase A1 | ABQ95989.1 | 4,22 *** | 2,59 *** | 3,52 ** | 2,76 ** |
40 | Phospholipase A1 | ABQ95989.1 | 3,65 ** | 2,57 ** | 1,59 ** | 2,27 * |
Glycolysis | ||||||
43 | Phosphoglycerate kinase | ABB87110 | 0,79 | 2,29 * | n.d. | n.d. |
Heat shock proteins | ||||||
5 | Chloroplast small heat shock protein class I | AAQ19680.1 | 0,24 ** | 0,23 ** | 0,25 * | 0,27 * |
27 | Heat shock protein (HSP70) | XP_002512741 | 0,87 | 0,40 * | n.d. | 0,68 * |
28 | 101Â kDa heat shock protein | AAC83688.2 | 0,85 | 1,13 | 0,48 ** | 0,98 |
Proteases | ||||||
47 | Leucine aminopeptidase, chloroplastic | P31427.2 | 2,35 * | 2,16 ** | 1,47 * | n.d. |
48 | Leucine aminopeptidase, chloroplastic | P31427.2 | 1,82 * | 1,19 | 3,06 ** | 2,16 * |
49 | Leucine aminopeptidase, chloroplastic | P31427.2 | 1,43 | 1,78 ** | 2,22 ** | 1,66 |
50 | Leucine aminopeptidase, chloroplastic | P31427.2 | n.d. | n.d. | 2,16 ** | 1,26 |
Pathogenesis related proteins | ||||||
17 | Putative PR-10 type pathogenesis-related protein | BAJ25784.1 | 0,39 * | 0,75 | 0,93 | 0,79 |
Cytoskeleton | ||||||
30 | Actin | BAK57343.1 | 0,47 ** | 1,06 | 0,72 * | 1,20 |
Unidentified proteins | ||||||
7 | Not identified | Â | 0,40 ** | 0,57 ** | 0,57 ** | 0,52 ** |
8 | Not identified | Â | 0,60 * | 0,44 * | 0,39 * | 0,22 * |
9 | Not identified | Â | 0,26** | 0,14** | n.d. | n.d. |
15 | Not identified | Â | 0,46 | 0,46 * | 0,29 * | 0,44 * |
16 | Not identified | Â | n.d. | 0,12 *** | 0,09 *** | 0,26 *** |
18 | Not identified | Â | 3,6 ** | 1,73 * | 1,63* | 1,45 |
23 | Not identified | Â | 3,64 * | 1,62 | 2,04 * | 3,12 ** |
25 | Not identified | Â | 2,20 ** | n.d. | 2,80 ** | n.d. |
26 | Not identified | Â | 1,72 | n.d. | 2,64 *** | 2,69 * |
29 | Not identified | Â | 0,99 | 0,73 * | 0,77 | 0,48 ** |
37 | Not identified | Â | 3,96 ** | 4,25 ** | 4,90 ** | 3,96 ** |
38 | Not identified | Â | 3,06 * | 2,85 *** | 3,88 *** | 2,15 |
41 | Not identified | Â | 2,52 | 1,62 * | 2,06 ** | 2,54 * |
42 | Not identified | Â | 1,68 * | 2,99 ** | 2,78 ** | n.d. |